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Sclerosis Complex
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Abstract
To date, little is known on the prevalence, incidence, and characteristics of 
intracranial aneurysms (IA) in patients with tuberous sclerosis complex (TSC). 
Based on our recent systematic review and two cases treated in our institute, 
we summarize the current evidence concerning the distinct characteristics of 
these aneurysms. In contrast to saccular IA in healthy adults, IA in TSC present 
commonly with large or even giant sac size and fusiform configuration, location 
predilection on the internal carotid artery remote from the branching zones, 
remarkable higher prevalence of pediatric cases, inverted sex-ratio, and suspected 
rapid growth. Although the pathogenesis of IA in TSC is still unclear, all these 
features might point to the crucial role a congenital defect in the development of 
IA rather than extrinsic or environmental factors. Furthermore, we discuss the 
enhancement of the regular magnetic resonance (MR) imaging screening suggested 
by the last recommendations of the 2012 International TSC Consensus Conference 
with cranial time-of-flight MR angiography in order to enable timely identification 
and treatment of frequently complex IA in TSC.
Keywords: tuberous sclerosis complex, intracranial aneurysms, subarachnoid 
hemorrhage, vascular disorders
1. Introduction
Tuberous sclerosis complex (TSC) is a rare multiorgan neuroendocrine disease 
and belongs to the group of phacomatoses. As a multisystemic genetic disorder with 
an autosomal dominant inheritance, it can affect any organ in the body [1]. In fact, 
the damage of one of two genes, TSC1 on chromosome 9 or TSC2 on chromosome 
16, that produce the tumor suppressors “hamartin” and “tuberin” [2, 3] results in 
the formation of benign tumors so-called hamartomas, such as subependymal giant 
cell tumors (SGCT) in the brain. Interestingly, more than 70% of TSC cases are new 
mutations, and among them, 75% are caused by TSC2 mutations [4].
The Vogt triad, a combination of epilepsy, mental retardation and adenoma 
sebaceum, is only present in 29% of the cases [5]. Epilepsy and mental retardation 
are respectively in 25 and 45% of the cases absent [5]. Because of the relatively mild 
disease manifestations, TSC was underdiagnosed until the 1980s [6].
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Cerebral aneurysms, also known as intracranial aneurysms (IA), are usually 
pouch-like (saccular) or spindle-shaped (fusiform) focal dilations in the wall of 
major arteries in the circle of Willis [7] that grow and present a certain risk of 
rupture. To date, arterial wall anomalies in TSC, particularly in aneurysms, were 
only described in the extracranial vasculature, such as aortic aneurysms or kidney 
aneurysms that were considered as the result of a congenital defect [8]. The distinct 
features of IA in these patients have not previously been addressed in the literature. 
Indeed, there are sporadic cases or small case series that reported the coexistence of 
IA and suggested their congenital origin.
First cases of TSC and IA were reported in 1974. The first patient was a 24-year 
old man who died after a subarachnoid hemorrhage (SAH), and the ruptured 
aneurysm of the right middle cerebral artery was diagnosed at autopsy [9]. The 
second patient was a 12-year old girl that presented in 1965 with a sudden blurry 
vision, and bilateral aneurysms of both internal carotid arteries (ICAs) involving 
the region of the carotid siphon were diagnosed [10].
Heritable connective tissue disorders such as Marfan syndrome, Ehlers-Danlos 
Syndrome, Loeys-Dietz syndrome and autosomal dominant polycystic kidney 
disease (ADPKD) are commonly associated with small saccular aneurysms [10]. Our 
recent systematic review of the English literature [11] is the first to describe the char-
acteristics of IA in TSC in comparison to the features of IA in healthy adults. Despite 
the eventuality of a congenital origin in TSC, there are some distinct features that 
characterize IA in TSC and differentiate them from common nonsyndromal IA. The 
purpose of this book chapter is to give an overview on the particular demographic, 
clinical, and radiologic features through a case illustration and discuss the possible 
natural history of IA in TSC patients. Patient informed consent was obtained.
2. Epidemiology
TSC is a rare condition. It has a birth incidence of 1 per 5800 and an incidence of 
1 per 30,000 in the general population [6]. From all cases between 1900 and 2018 
that were published in the English literature, only 33 patients with 42 IA were found 
[11]. But the incidence of IA in TSC might be higher as reported, as no screening 
trial has been performed yet. Furthermore, according to the recommendations of 
the 2012 TSC Consensus Conference [12], the MRI at diagnosis and every 1–3 years 
until the age of 25 years does not involve a special sequence for the vascular system, 
so-called time-of-flight MR angiography (TOF-MRA). This circumstance increases 
the risk of overlooking small aneurysms.
3. Characteristics of cerebral aneurysms in TSC
3.1 Case illustration
A 2.5-year-old child presented with new-onset focal seizures characterized by 
rightward head deviation and rhythmic movements of the right arm. Seizures were 
treated with Vigabatrin and were controlled. The child was born at term of 37 weeks 
gestation to a healthy mother who had an uncomplicated pregnancy. Further 
evaluation revealed multiple rhabdomyomas on echocardiography, subependymal 
tubers on cranial MRI leading to the diagnosis of TSC. Additionally, a left cavernous 
lesion was detected on MRI. A TOF-MRA showed an 8-mm-diameter left cavernous 
ICA aneurysm. A year later, a control MRI revealed a rapid growth of the aneurysm 
whose diameter reached 15.5 mm (Figure 1). At the age of 14 months, the child 
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presented with his mother to our neurosurgical department. Because of the aneurys-
mal rapid growth, the decision to treat the aneurysm was made and a digital subtrac-
tion angiography (DSA) was performed (Figure 2). The aneurysm was treated by 
embolization and parent vessel occlusion. After treatment, the patient tolerated the 
total occlusion of the ICA and no neurological deficits were noticed.
3.2 Demographic characteristics
The collected series [11] showed a specific demographic pattern. In particular, 
the male/female ratio was 1.9:1 and 66.7% of the patients were under the age of 18, 
among them 36.4% were 2 years of age or younger.
3.3 Clinical characteristics
Most IA in patients with TSC were diagnosed incidentally (36.4%) or due to a new 
onset of a neurological deficit (21.2%). IA were ruptured in only 7.1% of the cases [11].
3.4 Radiological characteristics
The most frequent location of IA was the anterior circulation (85.7%) in favor of 
the ICA (61.9%), where aneurysms originated remote from branching zones. Of the 
42 IA, 57.1% were large (size: 10–24 mm) or giant (size: ≥25 mm) and 45.2% had a 
fusiform configuration. Multiple aneurysms were seen only in 21.2% of the cases 
and a rapid growth was described and documented only in 2 patients (6%) [11, 13].
3.5 Summary and comparison with other series
Cerebral aneurysms in TSC have distinct demographic, clinical and radio-
logical features. Indeed, comparing TSC patients with those of the unruptured 
cerebral aneurysm Study of Japan (UCAS Japan) [14], significant differences 
are found between both series in the location on the ICA (61.9 vs. 34.1%, respec-
tively), large/giant size (57.1 vs. 10.4%, respectively) and proportion of multiple 
Figure 1. 
TOF-MRA showing an incidental fusiform left cavernous ICA aneurysm (8 mm) of a 2.5-year-old child (a) with 
a rapid aneurysmal growth (+7.5 mm diameter within 12 months of period). (b) ICA: internal carotid artery, 
TOF-MRA: time-of-flight-magnetic resonance angiography.
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IA (21.2 vs. 13.9%, respectively). Comparing TSC patients with individuals suf-
fering from giant aneurysms, [15] a difference in the location of the IA (anterior 
vs. posterior circulation, respectively) and in patients’ demographics are noticed, 
as giant IAs frequently manifest in women and during the fifth and sixth decades. 
Comparing TSC patients with pediatric series [16], several similarities are noticed, 
including the male predominance and high frequency of large/giant and fusiform 
aneurysms. However, the location on the ICA remote from branching zones 
remains the distinct characteristic of TSC.
A further comparison of IA in TSC patients with those with ADPKD [7] shows 
notable differences in the location on the ICA (61.9 vs. 16.8%, respectively), 
rupture status (7.1 vs. 37.9%, respectively), large/giant size (57.1 vs. 11.6%, respec-
tively), fusiform configuration (57.1 vs. 2.1%, respectively), proportion of multiple 
IA (21.2 vs. 45.3%, respectively) and patient’s median age (10.5 vs. 48.5 years, 
respectively).
The prevalence of IA in patients with TSC was retrospectively estimated to be 
0.74% during a 10-year period in a cohort of 404 patients [17]. This is definitely 
lower than the prevalence of IA in the general population (3.2%) [18], but slightly 
higher than that of the incidental findings of IA on brain MRI after screening of 
“asymptomatic individuals” in the general population (0.35%) [19]. In a large 
series of patients with heritable connective disorders, the prevalence of IA during 
a 10-year period was estimated to be 14% by Marfan syndrome, 12% by Ehlers-
Danlos syndrome and 28% by Loeys-Dietz syndrome [20]. Patients were adult 
individuals (mean age: 49.4 vs. 41.7 vs. 36.5, respectively) with a male/female 
equidistribution or female predominance (49 vs. 82 vs. 52%). IA were small (mean 
size: 4.4 vs. 6.9 vs. 4.8 mm), mostly saccular (75 vs. 64.3 vs. 87.5%), located on the 
ICA (75 vs. 85.7 vs. 62.5%) and unruptured (0 vs. 14.3 vs. 12.5%) [20].
In contrast, TSC patients are mostly young male individuals that present with 
asymptomatic, unruptured, large/giant, fusiform aneurysms that are located on 
the ICA, remote from the branching zones, with an eventual rapid growth. These 
Figure 2. 
DSA showing a lateral view of the fusiform left cavernous ICA aneurysm, obtained when the child was 
14 months old. DSA: digital subtraction angiography, ICA: internal carotid artery, OA: ophthalmic artery, 
PCoA: posterior communicating artery.
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characteristics may support the idea that IA in patients with TSC are characteristically 
different from other syndromal and nonsyndromal aneurysms.
4. Diagnostic modalities, treatment strategies, and outcome
4.1 Diagnostic modalities
In our systematic review [11], digital subtraction angiography (DSA) was the 
most common diagnostic modality (57.6%)for the identification of IA followed 
by MRI (30.3%). DSA remains the gold-standard in the diagnosis of IA. However, 
because of the crucial technological advances, MR angiography at 3 Tesla was found 
to have a high positive predictive value (mean: 93.4%) and high sensitivity for the 
detection of unruptured IA (74.1% for aneurysms <3 mm and 100% for aneurysms 
≥3 mm) [21]. Furthermore, contrast-free 3D-TOF-MRA at 3 Tesla accurately 
identifies the presence of IA and may replace DSA as a contrast-free, noninvasive, 
and nonradiation-based modality for the diagnosis and screening of IA [22].
4.2 Treatment strategies
Several treatment strategies were performed including aneurysm clipping and 
endovascular coiling. However, because of the complex morphology of IA with often-
times fusiform and/or giant aneurysm sac, many other techniques as surgical ICA 
occlusion after superficial temporal artery-MCA bypass or stent-assisted coiling or 
endovascular ICA occlusion were also performed [11]. In the last two decades, an 
increase in endovascular treatment of IA was noticed. Nevertheless, the proportion 
of microsurgical vs. endovascular treatment was almost the same in the pooled TSC 
cohort. This circumstance might be related to high prevalence of above-mentioned 
complex IA, which are less eligible for conventional endovascular treatment. 
However, recent improvements in neuro-interventional radiology such as flow-
diverters might enhance the indications to endovascular treatment.
4.3 Outcome
Among 16 patients that were operated, neurological outcome was reported in 
only 12 patients. Six patients had postoperatively no neurological deficits, three 
patients met an improvement of their focal neurological deficits (Oculomotor 
paresis/palsy, visual loss) and four patients experienced focal deficits (Oculomotor 
paresis, facial palsy and hemiparesis) [11].
5. Pathogenesis
The natural history of saccular aneurysms is to date well established, as higher 
hemodynamic shear stress and consequently stronger flow acceleration frequently 
promote aneurysm formation in cerebral vessel bifurcations [23]. In contrast, 
natural history of cerebral aneurysms remote from the branching zones as fusiform 
aneurysms still remains unclear. Some authors found a correlation between fusi-
form aneurysms and larger aortic root dimension, suggesting a shared pathophysi-
ological mechanism with aortopathy [24, 25]. However, the lack of histological 
findings of IA in TSC patients represents a considerable drawback in understanding 
aneurysm pathogenesis in this disease. The sole histological analysis was performed 
in 1980 at autopsy on the cerebral aneurysm wall of a 26-year-old woman. It 
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revealed a “relatively hypocellular hyaline fibrous tissue.” There were neither elastic 
fibers nor evidence of inflammation or necrosis [26].
The question of aneurysm formation always focused on their acquired vs. 
congenital nature. Many arguments plead in favor of a congenital defect of the 
arterial wall. First, the higher frequency of pediatric cases (66.7%) and the distinct 
location of IA unrelated to branching zones [11] might indicate the inferiority of 
extrinsic/environmental factors, which are considered to play a crucial role in the 
genesis of nonsyndromal IA in healthy adults [27]. Furthermore, the suspected 
rapid growth [11, 13] of these aneurysms could also support the presence of a 
genetic predisposition to IA development. Moreover, there is evidence of the 
pathogenesis of extracranial aneurysms in TSC that are likely caused by disorders of 
the connective tissue [28–31]. In fact, the postoperative pathologic examination of a 
large thoracoabdominal aneurysm wall of a 3-year-old child with a TSC2 mutation 
revealed a subintimal proliferation of smooth muscle cells (SMC) [32]. Further, it 
was demonstrated that the de-differentiation of aortic SMC through the activation 
of mammalian target of rapamycin complex 1 (mTORC1) signaling, characterized 
by increased proliferation of SMC and decreased expression of contractile proteins, 
contributed to the formation of the aneurysm [32]. Indeed, in vitro and in vivo 
evidence that the effect of TSC2 deficiency on vascular SMC is primarily driven by 
increased mTORC1 signaling was provided [32]. And these findings plead in favor 
of a coexistence of both diseases rather than a coincidence.
Therefore, genetic and histopathological studies must further investigate the 
anomalies of the vascular connective tissue in TSC, especially in the wall of intra-
cranial aneurysms to better understand IA formation.
6. Recommendations
Morbidity and quality of life during adulthood in patients with TSC are deter-
mined by the neurological manifestations [33]. Life expectancy can be reduced 
by uncontrolled seizures and tuber burden that significantly affect the cognitive 
impairment of patients [34]. Indeed, 13 cases of “unclear death circumstances” 
preceded by seizures were retrospectively reported among 639 patients with TSC 
in two different investigations at the Mayo Clinic [35] and the Bath TSC Clinic [36]. 
Status epilepticus was listed in 9 cases and sudden unexplained death in epilepsy in 
4 cases. Because of advances in diagnostic procedures and medical management, life 
expectancy of patients with TSC has drastically improved during the last 2 decades 
and the number of patients who survive to middle age and beyond is increasing [37].
The relatively young age of the individuals with TSC, the disproportionally high 
number of large/giant IA and the well-described rapid aneurysm growth in two 
children are sufficient arguments to prompt aneurysm treatment. Additionally, 
three cases of SAH were described. As long as the real incidence of IA in TSC 
remains unknown, the risk of aneurysm rupture in this population cannot be 
estimated. Therefore, the enhancement of the 2012 International TSC Consensus 
Conference with a cranial TOF-MRA at diagnosis and at the control examinations 
every 1–3 years might be reasonable for young individuals [11]. Prospective IA 
screening studies on a national and even international scale are urgently needed.
7. Conclusion
The epidemiology and pathogenesis of intracranial aneurysm formation in 
patients with TSC remains unclear. IA in TSC seem to have distinct characteristics 
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that differentiate them from other individuals with IA. Several demographic, 
clinical and radiological arguments plead in favor of a coexistence of both entities 
rather than a coincidence, due to a congenital defect of the arterial wall. Therefore, 
large population-based patient registers, prospective screening studies as well as 
genetic and histopathological studies are required to improve the understanding of 
IA formation in TSC. In this way, regular MRI screening with TOF-MRA seems to 
be appropriate in TSC young individuals.
8. Conclusions
Aneurysms were well described in the extracranial vasculature of patients 
with tuberous sclerosis complex (TSC) such as aortic and kidney aneurysms, 
where anomalies of the vascular connective tissue have been histopathologically 
and genetically investigated. In contrast, cerebral aneurysms remain uncommon 
and their incidence totally unknown. A recent systematic review of the literature 
found 33 patients with 42 intracranial aneurysms (IA) that seem to have distinct 
characteristics compared to other syndromal and nonsyndromal IA. Indeed, TSC 
patients with cerebral aneurysms were found to be young male individuals that 
present with large/giant, fusiform, mostly asymptomatic, and unruptured aneu-
rysms, located on the internal carotid artery unrelated to branching zones, with 
an eventual rapid growth. Although the pathogenesis of IA in TSC is still unclear, 
several demographic, clinical, and radiological arguments plead in favor of the 
coexistence of both entities, due to a congenital defect of the cerebral arterial wall. 
As long as the real incidence of IA in TSC remains unknown, the risk of aneurysm 
rupture in this population cannot be estimated, especially that three cases of sub-
arachnoid hemorrhage were reported. Therefore, prospective screening, genetic 
and histopathological studies are urgently needed to improve the understanding 
of the pathogenesis and epidemiology of IA formation in TSC. This cannot be 
achieved without enhancing the recommendations of the 2012 International 
TSC Consensus Conference with a cranial TOF-MRA at diagnosis and all regular 
screening consultations.
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